JPMorgan Chase & Co. Issues Pessimistic Forecast for Docusign (NASDAQ:DOCU) Stock Price

Docusign (NASDAQ:DOCU) had its price objective cut by JPMorgan Chase & Co. from $78.00 to $65.00 in a research report issued on Wednesday,Benzinga reports. The firm currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s target price points to a potential upside of 36.13% from the company’s previous close.

Other equities research analysts also recently issued research reports about the company. BTIG Research reaffirmed a “buy” rating and set a $70.00 target price on shares of Docusign in a report on Wednesday. Cantor Fitzgerald reiterated an “outperform” rating on shares of Docusign in a report on Wednesday, December 17th. Bank of America reduced their price target on shares of Docusign from $102.00 to $82.00 and set a “neutral” rating for the company in a research report on Friday, December 5th. Morgan Stanley decreased their price objective on shares of Docusign from $90.00 to $69.00 and set an “equal weight” rating for the company in a research note on Wednesday. Finally, Robert W. Baird dropped their price objective on shares of Docusign from $75.00 to $55.00 and set a “neutral” rating on the stock in a report on Wednesday. Five investment analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $67.73.

Docusign Stock Performance

Shares of NASDAQ DOCU traded up $0.21 during mid-day trading on Wednesday, hitting $47.75. The stock had a trading volume of 7,088,167 shares, compared to its average volume of 4,843,658. The company has a 50 day moving average of $51.11 and a two-hundred day moving average of $64.46. Docusign has a twelve month low of $40.16 and a twelve month high of $94.67. The firm has a market cap of $9.56 billion, a PE ratio of 33.32, a PEG ratio of 2.04 and a beta of 1.03.

Docusign (NASDAQ:DOCU) last issued its earnings results on Tuesday, March 17th. The company reported $1.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.95 by $0.06. The company had revenue of $836.86 million during the quarter, compared to analyst estimates of $828.23 million. Docusign had a return on equity of 15.02% and a net margin of 9.57%.The firm’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter last year, the business posted $0.86 EPS. Equities research analysts predict that Docusign will post 1.17 EPS for the current fiscal year.

Insider Activity

In related news, CRO Paula Hansen sold 6,000 shares of the firm’s stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $67.05, for a total transaction of $402,300.00. Following the sale, the executive owned 68,970 shares in the company, valued at approximately $4,624,438.50. This trade represents a 8.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider James P. Shaughnessy sold 12,000 shares of Docusign stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $67.03, for a total transaction of $804,360.00. Following the completion of the transaction, the insider directly owned 54,550 shares of the company’s stock, valued at $3,656,486.50. The trade was a 18.03% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 51,477 shares of company stock valued at $3,521,607 in the last quarter. Company insiders own 1.66% of the company’s stock.

Institutional Investors Weigh In On Docusign

Hedge funds have recently modified their holdings of the company. Rockefeller Capital Management L.P. increased its stake in shares of Docusign by 11.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 238,114 shares of the company’s stock valued at $16,287,000 after purchasing an additional 24,842 shares in the last quarter. Corient Private Wealth LLC grew its holdings in Docusign by 2.5% in the fourth quarter. Corient Private Wealth LLC now owns 29,608 shares of the company’s stock valued at $2,026,000 after purchasing an additional 732 shares during the period. Kera Capital Partners Inc. grew its holdings in Docusign by 347.8% in the fourth quarter. Kera Capital Partners Inc. now owns 16,556 shares of the company’s stock valued at $1,132,000 after purchasing an additional 12,859 shares during the period. Alberta Investment Management Corp increased its position in shares of Docusign by 490.2% in the fourth quarter. Alberta Investment Management Corp now owns 72,000 shares of the company’s stock valued at $4,925,000 after buying an additional 59,800 shares in the last quarter. Finally, Mercer Global Advisors Inc. ADV increased its position in shares of Docusign by 32.9% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 65,594 shares of the company’s stock valued at $4,487,000 after buying an additional 16,250 shares in the last quarter. 77.64% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Q4 beat and upbeat guidance — DocuSign reported Q4 adjusted EPS of $1.01 and revenue of $836.9M, topping consensus; management provided a slightly stronger-than-expected near‑term revenue outlook. This is the main catalyst for the intraday uptick. DocuSign Beats Q4
• Positive Sentiment: $2.0 billion buyback increase — The company expanded its share repurchase program by $2B, a significant capital return action that supports EPS and signals confidence from the board. PR Newswire Release
• Positive Sentiment: IAM/AI momentum — Management highlighted IAM customers generating >$350M ARR and expanding AI partnerships, which investors view as durable upsell/retention levers beyond e‑signature. Earnings Call Transcript
• Neutral Sentiment: Longer‑term bull case surfaced in commentary — Some deep-dive pieces argue DOCU is oversold given improving margins and Rule-of-40 progress; useful for patient investors but may be less relevant to near‑term price action. Seeking Alpha Analysis
• Negative Sentiment: Multiple analyst price‑target cuts — Several firms trimmed targets this morning (RBC to $55, UBS to $54, Robert W. Baird to $55, Wells Fargo to $60, Citizens from $124→$86), reflecting caution on growth/profitability. These downgrades cap upside and explain mixed trader sentiment despite the beat. Benzinga: analyst moves
• Negative Sentiment: Analysts want faster revenue acceleration — Coverage notes that while execution and AI products look promising, many analysts are waiting for sustained 10%+ revenue growth; that expectation gap is driving the recent target cuts and volatility. MSN Article

Docusign Company Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.